Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
Research & Development
Takeda Pharmaceutical Co Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Research & Development
-¥695B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-8%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Research & Development
-¥358.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Research & Development
-¥307.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
Eisai Co Ltd
TSE:4523
|
Research & Development
-¥173.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Research & Development
-¥169.1B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
Astellas Pharma Inc
TSE:4503
|
Research & Development
-¥351B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-10%
|
See Also
What is Takeda Pharmaceutical Co Ltd's Research & Development?
Research & Development
-695B
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Research & Development amounts to -695B JPY.
What is Takeda Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-8%
Over the last year, the Research & Development growth was -13%.